title: Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice.
abstract: This experiment was conducted to evaluate whether pretreatment with fenofibrate could mitigate acute lung injury (ALI) in a mice model of intestinal ischemia/reperfusion (I/R). Male C57BL/6 mice were randomly assigned into three groups (n = 6): sham, intestinal I/R + vehicle, and intestinal I/R + fenofibrate. Intestinal I/R was achieved by clamping the superior mesenteric artery. Fenofibrate (100 mg/kg) or equal volume of vehicle was injected intraperitoneally 60 minutes before the ischemia. At the end of experiment, measurement of pathohistological score, inflammatory mediators and other markers were performed. In addition, a 24-hour survival experiment was conducted in intestinal I/R mice treated with fenofibrate or vehicle. The chief results were as anticipated. Pathohistological evaluation indicated that fenofibrate ameliorated the local intestine damage and distant lung injury. Pretreatment with fenofibrate significantly decreased inflammatory factors in both the intestine and the lung. Consistently, renal creatine levels and hepatic ALT levels were significantly decreased in the fenofibrate group. Moreover, serum systemic inflammatory response indicators were significantly alleviated in the fenofibrate group. In addition, fenofibrate administration significantly improved the survival rate. Collectively, our data indicated that pretreatment with fenofibrate prior to ischemia attenuated intestinal I/R injury and ALI.
authors.affiliation: Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College&Chinese Academy of Medical Sciences, Beijing, 100730, China.
authors.forename: Qiankun
authors.initials: Q
authors.lastname: Zhu
authors.affiliation: Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College&Chinese Academy of Medical Sciences, Beijing, 100730, China.
authors.forename: Guizhen
authors.initials: G
authors.lastname: He
authors.affiliation: Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College&Chinese Academy of Medical Sciences, Beijing, 100730, China.
authors.forename: Jie
authors.initials: J
authors.lastname: Wang
authors.affiliation: Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College&Chinese Academy of Medical Sciences, Beijing, 100730, China.
authors.forename: Yukang
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Department of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College&Chinese Academy of Medical Sciences, Beijing, 100730, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Chen
mesh_terms: D055371:Acute Lung Injury / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D004195:Disease Models, Animal; D011345:Fenofibrate / Q000494:pharmacology*; D007422:Intestines / Q000098:blood supply / Q000293:injuries* / Q000473:pathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D015427:Reperfusion Injury / Q000150:complications / Q000473:pathology / Q000517:prevention & control*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D011345:Fenofibrate